Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123132735 | 12313273 | 5 | F | 20160913 | 20160428 | 20160916 | PER | US-PFIZER INC-2016217197 | PFIZER | 81.00 | YR | F | Y | 75.75000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123132735 | 12313273 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | 5 MG, UNK | U | M39808 | 203214 | 5 | MG | TABLET | ||||||
| 123132735 | 12313273 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | 5 MG, UNK | U | 0 | 5 | MG | ||||||||
| 123132735 | 12313273 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | UNK (TWO AND A HALF MG ) | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123132735 | 12313273 | Abdominal discomfort | |
| 123132735 | 12313273 | Abdominal distension | |
| 123132735 | 12313273 | Abdominal pain upper | |
| 123132735 | 12313273 | Abnormal faeces | |
| 123132735 | 12313273 | Blood cholesterol increased | |
| 123132735 | 12313273 | Flatulence | |
| 123132735 | 12313273 | Frequent bowel movements | |
| 123132735 | 12313273 | Nausea | |
| 123132735 | 12313273 | Rash | |
| 123132735 | 12313273 | Tinea pedis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |